MedTrace Logo

Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain

NCT03209895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2017-07-06

No results posted yet for this study

Summary

This study is designed to evaluate the effectiveness of a proprietary nutritional supplement that contains Krill Oil (KO), astaxanthin (AX) and hyaluronic acid (HA) to reduce pain and discomfort in participants, compared to an inert placebo (palm oil) control and to a positive control (glucosamine-chondroitin). The purpose of the study is to determine if the combination of KO, AX, and HA will benefit participants with joint pain.

Conditions

Interventions

DIETARY_SUPPLEMENT

Joint Health Product

Krill oil, Astaxanthin, Hyaluronic Acid Formulation, 353 mg per day; Softgel capsule

DIETARY_SUPPLEMENT

Placebo

Palm oil Softgel capsule

DIETARY_SUPPLEMENT

Glucosamine / Chondroitin

Glucosamine 1500 mg, Chondroitin 1200 mg per day

Sponsors & Collaborators

  • U.S. Nutraceuticals, LLC

    lead INDUSTRY

Principal Investigators

  • Eshwari Koovor, M.B.B.S. · PI

  • Herjit Pannu, MD · PI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-08
Primary Completion
2011-06-13
Completion
2011-06-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209895 on ClinicalTrials.gov